Gabapentin Oral Solution Suppliers & Bulk Manufacturers
Available Forms: Oral solution
Available Strengths: 250 mg/5 mL
Reference Brands: US: Neurontin®, Gralise®, Horizant® (ER); EU: Neurontin®, Gabantin®
Category:
Antipsychotropic Drugs
Gabapentin (Neurontin®, Gralise®) is used for epilepsy, nerve pain, and RLS. Available in oral forms ranging from 100 mg to 800 mg, it's in high demand globally. Source Gabapentin API and finished products from trusted pharma suppliers via Pharmatradz.com—your B2B pharma trading network.
Gabapentin Oral solution is available in Oral solution
and strengths such as 250 mg/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Gabapentin Oral solution is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Gabapentin Oral solution can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Gabapentin oral solution is FDA-approved in the USA for treating partial seizures and postherpetic neuralgia. It is available as a prescription medication under the Federal Food, Drug, and Cosmetic Act, with specific guidelines for renal dose adjustment and CNS-related adverse effects. In the European Union, gabapentin is authorized via national procedures for epilepsy and neuropathic pain, with country-specific brand names and formulations. EU labeling includes warnings for CNS depression, suicidal ideation, and withdrawal symptoms. It’s classified as a prescription-only medicine (POM). To explore global availability and sourcing, visit Pharmatradz.com
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing